To investigate the effect of inhibiting MMP12 on colorectal cancer or body weight, we administered MMP12 inhibitor (MMP408) and its combination with a classic clinical anti-colon cancer drug (5-FU) in ApcMin/+ mice (Fig. 6A). This evidence concerns the gene MMP12 and malignant colon neoplasm.